Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by biorun


V.SBM

Key pieces

My take: 1. Strategic planning, looks like more and more emphasis on...

July 13, 2023

V.SBM

RE:RE:RE:RE:Financials out last night

It's not looking like royalties from last quarter. First step is to send...

July 4, 2023

V.SBM

RE:TFC-1067 / R&F

What I take away from this analysis is that it could possibly be considered a...

July 4, 2023

V.SBM

RE:AbbVies-Allergan-TFC-1067

Nice find. Any way to tell if this is recently posted? "While the two...

July 3, 2023

V.SBM

RE:RE:RE:Financials out last night

Sales to R&F ceased some time ago. So that would mean that AbbVie is now...

June 30, 2023

V.SBM

RE:RE:RE:RE:RE:Here's the thing

Yes it is a good post in my view as well.

June 30, 2023

V.SBM

RE:RE:Here's the thing

Link below: This is probably what will happen to Sirona, if we are to see...

June 29, 2023

V.SBM

Here's the thing

None, and I mean none of these updates mean a darn thing to the market UNTIL...

June 28, 2023

V.SBM

RE:Trenibrorher@w:o - Novartis&Sirona?!

"Through further research and bringing together all the existing details...

June 25, 2023

V.SBM

RE:RE:RE:RE:RE:RE:RE:RE:Don't waste time with individual license agreements for TFC1

They understand what they put us all through so no surprise they are being...

June 18, 2023

V.SBM

RE:RE:RE:RE:Don't waste time with individual license agreements for TFC1

The scientific results presented as such I would think are in hand from the...

June 16, 2023

V.SBM

RE:RE:Was this just another waste of shareholder's money?

Whoah. I guess never bring a knife to a situation where there could be a gun...

June 6, 2023

V.SBM

RE:SBM mgmt, get on with it

The shelves are full with products that don't work well and yet still...

June 1, 2023

V.SBM

RE:New JUVÉDERM Product

Important reference point for 1326 as a reflection of new tech in same market...

May 31, 2023

V.SBM

Well ok! News

"Monica has launched several disruptive technologies including BOTOXand...

May 25, 2023

V.SBM

Focus on the scientific assets

Geraldine was able to go public with the results for anti-aging. That is a...

May 23, 2023

V.SBM

RE:A better runway

Agree. The price reached 16 cents overseas before some housekeeping on legacy...

May 12, 2023

V.SBM

RE:RE:RE:RE:Pandora and others

Yes, looks like there is some interest in buying at these levels as well. I...

May 11, 2023

V.SBM

Wim Hoff meets Geraldine D

If you follow his space on inflammation control through cold therapy to treat...

May 11, 2023

V.SBM

RE:1067 permanently removed my dark spots

I tried it as well when it first came out and it was equally effective for me...

May 9, 2023

Featured Company